과제정보
We thank Dr. Ha-Kyu Jeong at Samsung Electronics Company for his technical support and valuable advice in the application of the chemical exchange dependent saturation transfer technique and Dr. Jinyuan Zhou at Johns Hopkins University School of Medicine in Baltimore, USA for supporting the CEST sequence and for his fruitful advice. In addition, the authors thank Miss Soo-Jin Kim for providing statistical support.
참고문헌
- Kogan F, Hariharan H, Reddy R. Chemical Exchange Saturation Transfer (CEST) imaging: description of technique and potential clinical applications. Curr Radiol Rep 2013;1:102-114 https://doi.org/10.1007/s40134-013-0010-3
- Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003;9:1085-1090 https://doi.org/10.1038/nm907
- Oh JH, Kim HG, Woo DC, Jeong HK, Lee SY, Jahng GH. Chemical-exchange-saturation-transfer magnetic resonance imaging to map gamma-aminobutyric acid, glutamate, myoinositol, glycine, and asparagine: phantom experiments. J Korean Phys Soc 2017;70:545-553 https://doi.org/10.3938/jkps.70.545
- van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011;65:927-948 https://doi.org/10.1002/mrm.22761
- Yadav NN, Jones CK, Hua J, Xu J, van Zijl PC. Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imaging. Magn Reson Med 2013;69:966-973 https://doi.org/10.1002/mrm.24655
- Goerke S, Milde KS, Bukowiecki R, Kunz P, Klika KD, Wiglenda T, et al. Aggregation-induced changes in the chemical exchange saturation transfer (CEST) signals of proteins. NMR Biomed 2017 Jan [Epub]. https://doi.org/10.1002/nbm.3665
- Jahng GH, Choi W, Chung JJ, Kim ST, Rhee HY. Mapping exchangeable protons to monitor protein alterations in the brain of an Alzheimer's disease mouse model by using MRI. Curr Alzheimer Res 2018;15:1343-1353 https://doi.org/10.2174/1567205015666180911143518
- Wang R, Li SY, Chen M, Zhou JY, Peng DT, Zhang C, et al. Amide proton transfer magnetic resonance imaging of Alzheimer's disease at 3.0 Tesla: a preliminary study. Chin Med J (Engl) 2015;128:615-619 https://doi.org/10.4103/0366-6999.151658
- Zaiss M, Schmitt B, Bachert P. Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra. J Magn Reson 2011;211:149-155 https://doi.org/10.1016/j.jmr.2011.05.001
- Jones CK, Huang A, Xu J, Edden RA, Schar M, Hua J, et al. Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage 2013;77:114-124 https://doi.org/10.1016/j.neuroimage.2013.03.047
- Desmond KL, Moosvi F, Stanisz GJ. Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T. Magn Reson Med 2014;71:1841-1853 https://doi.org/10.1002/mrm.24822
- Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 2010;25:1071-1076 https://doi.org/10.3346/jkms.2010.25.7.1071
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944 https://doi.org/10.1212/WNL.34.7.939
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308 https://doi.org/10.1001/archneur.56.3.303
- Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992 https://doi.org/10.1001/archneur.58.12.1985
- Zhu H, Jones CK, van Zijl PC, Barker PB, Zhou J. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med 2010;64:638-644 https://doi.org/10.1002/mrm.22546
- Zhao X, Wen Z, Huang F, Lu S, Wang X, Hu S, et al. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med 2011;66:1033-1041 https://doi.org/10.1002/mrm.22891
- Jahng GH, Oh JH. Physical modeling of chemical exchange saturation transfer imaging. Prog Med Phys 2017;28:135-143 https://doi.org/10.14316/pmp.2017.28.4.135
- Holmes HE, Colgan N, Ismail O, Ma D, Powell NM, O'Callaghan JM, et al. Imaging the accumulation and suppression of tau pathology using multiparametric MRI. Neurobiol Aging 2016;39:184-194 https://doi.org/10.1016/j.neurobiolaging.2015.12.001
- Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 2008;60:842-849 https://doi.org/10.1002/mrm.21712
- Chen L, Wei Z, Chan KWY, Cai S, Liu G, Lu H, et al. Protein aggregation linked to Alzheimer's disease revealed by saturation transfer MRI. Neuroimage 2019;188:380-390 https://doi.org/10.1016/j.neuroimage.2018.12.018
- Goerke S, Zaiss M, Kunz P, Klika KD, Windschuh JD, Mogk A, et al. Signature of protein unfolding in chemical exchange saturation transfer imaging. NMR Biomed 2015;28:906-913 https://doi.org/10.1002/nbm.3317
- Wells JA, O'Callaghan JM, Holmes HE, Powell NM, Johnson RA, Siow B, et al. In vivo imaging of tau pathology using multi-parametric quantitative MRI. Neuroimage 2015;111:369-378 https://doi.org/10.1016/j.neuroimage.2015.02.023
- Haris M, Nath K, Cai K, Singh A, Crescenzi R, Kogan F, et al. Imaging of glutamate neurotransmitter alterations in Alzheimer's disease. NMR Biomed 2013;26:386-391 https://doi.org/10.1002/nbm.2875
- Haris M, Singh A, Cai K, Nath K, Crescenzi R, Kogan F, et al. MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease. J Neurosci Methods 2013;212:87-93 https://doi.org/10.1016/j.jneumeth.2012.09.025
- Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999;155:853-862 https://doi.org/10.1016/S0002-9440(10)65184-X
- Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12:383-388 https://doi.org/10.1016/0165-6147(91)90609-V
- Chu WJ, Hetherington HP, Kuzniecky RJ, Vaughan JT, Twieg DB, Faught RE, et al. Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy? A 31P NMR study. Neurology 1996;47:756-760 https://doi.org/10.1212/WNL.47.3.756
- Mandal PK, Akolkar H, Tripathi M. Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis 2012;31 Suppl 3:S75-S86 https://doi.org/10.3233/JAD-2012-120166